Citadel Advisors’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,400
| Closed | -$347K | – | 14017 |
|
|
2020
Q4 | $347K | Sell |
4,400
-2,300
| -34% | -$135K | ﹤0.01% | 8814 |
|
|
2020
Q3 | $294K | Sell |
6,700
-1,700
| -20% | -$83.8K | ﹤0.01% | 8167 |
|
|
2020
Q2 | $372K | Sell |
8,400
-800
| -9% | -$29.8K | ﹤0.01% | 7562 |
|
|
2020
Q1 | $330K | Sell |
9,200
-600
| -6% | -$34.1K | ﹤0.01% | 7162 |
|
|
2019
Q4 | $695K | Buy |
9,800
+1,000
| +11% | +$72.5K | ﹤0.01% | 6262 |
|
|
2019
Q3 | $658K | Buy |
8,800
+4,400
| +100% | +$373K | ﹤0.01% | 6280 |
|
|
2019
Q2 | $355K | Sell |
4,400
-1,400
| -24% | -$98.4K | ﹤0.01% | 7326 |
|
|
2019
Q1 | $388K | Buy |
+5,800
| New | +$439K | ﹤0.01% | 7214 |
|
|
2018
Q4 | – | Sell |
-18,500
| Closed | -$1.7M | – | 10053 |
|
|
2018
Q3 | $1.7M | Buy |
18,500
+11,200
| +153% | +$1.07M | ﹤0.01% | 4663 |
|
|
2018
Q2 | $718K | Buy |
7,300
+4,500
| +161% | +$503K | ﹤0.01% | 5789 |
|
|
2018
Q1 | $312K | Sell |
2,800
-3,200
| -53% | -$359K | ﹤0.01% | 6682 |
|
|
2017
Q4 | $617K | Buy |
+6,000
| New | +$598K | ﹤0.01% | 5349 |
|
|
2016
Q1 | – | Sell |
-4,200
| Closed | -$261K | – | 8449 |
|
|
2015
Q4 | $261K | Buy |
+4,200
| New | +$256K | ﹤0.01% | 5428 |
|
|
2015
Q2 | – | Sell |
-1,400
| Closed | -$67K | – | 9242 |
|
|
2015
Q1 | $67K | Buy |
1,400
+600
| +75% | +$26.6K | ﹤0.01% | 7176 |
|
|
2014
Q4 | $35K | Buy |
+800
| New | +$32.7K | ﹤0.01% | 7460 |
|
|
2014
Q3 | – | Sell |
-9,100
| Closed | -$333K | – | 8530 |
|
|
2014
Q2 | $333K | Sell |
9,100
-5,600
| -38% | -$190K | ﹤0.01% | 4913 |
|
|
2014
Q1 | $496K | Buy |
14,700
+9,000
| +158% | +$297K | ﹤0.01% | 4355 |
|
|
2013
Q4 | $193K | Buy |
5,700
+800
| +16% | +$27.7K | ﹤0.01% | 5065 |
|
|
2013
Q3 | $156K | Buy |
+4,900
| New | +$130K | ﹤0.01% | 4994 |
|
Citadel Advisors's CMD Position: Q2 2021 in Review
Citadel Advisors sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 1,031,759 shares — an estimated $82.4M sold.
Citadel Advisors first reported a position in CMD in Q3 2013 and held it in 25 quarters. The position peaked at $82.4M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Citadel Advisors reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Citadel Advisors sold 1,031,759 Cantel Medical Corporation shares in Q2 2021, an estimated $82.4M.
- Citadel Advisors first reported a position in Cantel Medical Corporation in Q3 2013 and held it in 25 quarters.
- Citadel Advisors's Cantel Medical Corporation position peaked at $82.4M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.